静脉注射乙氨基引起的严重低血压的危险因素
Yu-Ri Choi1, Ji-In Park1, Seong-Sim An1
1Department of Pharmacy, Seoul St. Mary's Hospital, Seoul, Korea.
Pharmacoepidemiology and drug safety
|August 25, 2025
概括
在患有血性恶性瘤的患者中,静脉注射乙氨基可引起严重的低血压. 危险因素包括高烧,急性损伤和细菌血症,需要密切监测血压.
科学领域:
- 药理学
- 危急护理医学
- 血液学
背景情况:
- 静脉注射的乙氨基 (AAP) 由于其快速作用,经常用于危急病患者的发烧.
- 然而,静脉注射AAP后低血压的风险,特别是在易受感染的群体中,需要进一步调查.
研究的目的:
- 在血液恶性瘤患者静脉注射亚美诺芬后确定严重低血压的危险因素.
主要方法:
- 对接受静脉注射AAP的住院血液瘤患者进行回顾性研究.
- 严重低血压患者与没有严重低血压患者的比较.
- 用单变量和多变量分析来确定风险因素.
主要成果:
- 37名患者出现严重的低血压;111名患者作为对照.
- 确定的危险因素: 服药前体温升高,急性损伤和细菌性病.
- 药物注射前平均动脉压较高与低血压风险降低有关.
结论:
- 血性恶性瘤患者接受静脉注射AAP可能会出现严重的低血压.
- 预先存在的疾病,如发烧,AKI和细菌病,会增加这种风险.
- 在静脉注射AAP时密切监测血压对于患者的安全至关重要.
更多相关视频
相关概念视频
Hemodialysis II: Procedure and Complications
129
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
129
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Alterations in Blood Pressure
1.5K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.5K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
114
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
114
Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153


